Cannabidiol Expanded Access Study in Medically Refractory Sturge-Weber Syndrome

Active, not recruiting

Phase 1/2 Results N/A

Summary of Purpose

The purpose of this study is to determine the tolerability and optimal dose of cannabidiol (CBD) as an simultaneous treatment in children and young adults with Sturge-Weber syndrome (SWS) and drug resistant epilepsy.

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 28 February 2018.

1 Dec 2014 5 Jan 2015 1 Jun 2019 1 Jun 2019 1 Feb 2018 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Design

  • Masking: Open Label
  • Purpose: Treatment
  • Endpoint: Safety/Efficacy Study
  • Intervention: Single Group Assignment

Contacts